Krauß, S.; So, J.; Hambrock, M.; Köhler, A.; Kunath, M.; Scharff, C.; Wessling, M.; Grzeschik, K.-H.; Schneider, R.; Schweiger, S.: Point mutations in GLI3 lead to misregulation of its subcellular localization. PLoS ONE 4, S. e7471 - e7471 (2009)
Aranda-Orgillés, B.; Aigner, J.; Kunath, M.; Lurz, R.; Schneider, R.; Schweiger, S.: Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A. PLoS One 3 (10), S. e3507 - e3507 (2008)
Aranda-Orgillés, B.; Aigner, J.; Kunath, M.; Lurz, R.; Schneider, R.; Schweiger, S.: Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A. PLoS One 3 (10), S. e3507 - e3507 (2008)
Krauß, S.; Foerster, J.; Schneider, R.; Schweiger, S.: Protein Phosphatase 2A and Rapamycin regulate the nuclear localization and activity of the transcription factor GLI3. Cancer Research 68 (12), S. 4658 - 4665 (2008)
So, J.; Müller, I.; Kunath, M.; Herrmann, S.; Ullmann, R.; Schweiger, S.: Diagnosis of a terminal deletion of 4p with duplication of Xp22.31 in a patient with findings of Opitz G/BBB syndrome and Wolf-Hirschhorn syndrome. American Journal of Medical Genetics Part A 146A (1), S. 103 - 109 (2008)
Winter, J.; Kunath, M.; Roepcke, S.; Krause, S.; Schneider, R.; Schweiger, S.: Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1. BMC Molecular Biology [Elektronische Ressource] 8 (1), S. 105 - 133 (2007)
So, J.; Suckow, V.; Kijas, Z.; Kalscheuer, V.; Moser, B.; Winter, J.; Baars, M.; Firth, H.; Lunt, P.; Hamel, B.et al.; Meinecke, P.; Moraine, C.; Odent, S.; Schinzel, A.; van der Smagt, J.J.; Devriendt, K.; Albrecht, B.; Gillessen-Kaesbach, G.; van der Burgt, I.; Petrij, F.; Faivre, L.; McGaughran, J.; McKenzie, F.; Opitz, J. M.; Cox, T.; Schweiger, S.: Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. American Journal of Medical Genetics Part A 132A (1), S. 1 - 7 (2006)
So, J.; Suckow, V.; Kijas, Z.; Kalscheuer, V.; Moser, B.; Winter, J.; Baars, M.; Firth, H.; Lunt, P.; Hamel, B.et al.; Meinecke, P.; Moraine, C.; Odent, S.; Schinzel, A.; van der Smagt, J.J.; Devriendt, K.; Albrecht, B.; Gillessen-Kaesbach, G.; van der Burgt, I.; Petrij, F.; Faivre, L.; McGaughran, J.; McKenzie, F.; Opitz, J. M.; Cox, T.; Schweiger, S.: Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. American Journal of Medical Genetics Part A 132A (1), S. 1 - 7 (2006)
Shoichet, S. A.; Duprez, L.; Hagens, O.; Waetzig, V.; Menzel, C.; Herdegen, T.; Schweiger, S.; Dan, B.; Vamos, E.; Ropers, H.-H.et al.; Kalscheuer, V. M.: Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy. Human Genetics 118 (5), S. 559 - 567 (2006)
Foerster, J.; Nolte, I.; Junge, J.; Bruinenberg, M.; Schweiger, S.; Spaar, K.; van der Steege, G.; Ehlert, C.; Mulder, M.; Kalscheuer, V.: Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis. The Journal of Investigative Dermatology: an International Journal for Research in Cutaneous Biology 124 (1), S. 99 - 102 (2005)
So, J.; Suckow, V.; Kijas, Z.; Kalscheuer, V. M.; Moser, B.; Winter, J.; Baars, M.; Firth, H.; Lunt, P.; Hamel, B.et al.; Meinecke, P.; Moraine, C.; Odent, S.; Schinzel, A.; van der Smagt, J.J.; Devriendt, K.; Albrecht, B.; Gillessen-Kaesbach, G.; van der Burgt, I.; Petrij, F.; Faivre, L.; McGaughran, J.; McKenzie, F.; Opitz, J. M.; Cox, T.; Schweiger, S.: Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. American Journal of Medical Genetics: Part A 132 (1), S. 1 - 7 (2005)
So, J.; Suckow, V.; Kijas, Z.; Kalscheuer, V. M.; Moser, B.; Winter, J.; Baars, M.; Firth, H.; Lunt, P.; Hamel, B.et al.; Meinecke, P.; Moraine, C.; Odent, S.; Schinzel, A.; van der Smagt, J.J.; Devriendt, K.; Albrecht, B.; Gillessen-Kaesbach, G.; van der Burgt, I.; Petrij, F.; Faivre, L.; McGaughran, J.; McKenzie, F.; Opitz, J. M.; Cox, T.; Schweiger, S.: Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. American Journal of Medical Genetics: Part A 132 (1), S. 1 - 7 (2005)
Foerster, J.; Nolte, I.; Schweiger, S.; Ehlert, C.; Bruinenberg, M.; Spaar, K.; van der Steege, G.; Mulder, M.; Kalscheuer, V. M.; Moser, B.et al.; Kijas, Z.; Seeman, P.; Ständer, M.; Sterry, W.; te Meerman, G.: Evaluation of the IRF-2 gene as a candidate for PSORS3. Journal of Investigative Dermatology 122 (1), S. 61 - 64 (2004)
Forschende des Max-Planck-Instituts für molekulare Genetik beschreiben gewebespezifische Ausbildung von architektonischen Streifen durch aktivierte Enhancer und CTCF-Elemente